Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 464 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 06/01/17
End: 07/17/24
Due: 07/17/25
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 05/02/19
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 03/31/06
Due: 03/31/07
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 10/10/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 10/31/03
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 01/31/07
Due: 01/31/08
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
Phase: N/A
Priority: Normal
Start: 11/27/20
End: 12/02/21
Due: 12/02/22
Phase: N/A
Priority: Normal
Start: 11/04/23
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/01/15
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 01/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 04/15/16
End: 03/26/18
Due: 03/26/19